Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive tumor. Nivolumab showed durable antitumor effect in patients with recurrent MPM and was approved for those patients in Japan in 2018. Immune related adverse event (irAE) is occurred in various organs and is suggestive to be related...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Respir Med Case Rep
Autores principales: Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, Mizugaki, Hidenori, Kikuchi, Eiki, Asahina, Hajime, Shinagawa, Naofumi, Konno, Satoshi
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378269/
https://ncbi.nlm.nih.gov/pubmed/32714828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101170
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares